Related references
Note: Only part of the references are listed.Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
Pascal Jezequel et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
Balakrishna Koneru et al.
CANCER RESEARCH (2020)
Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis
Yajing Zhang et al.
JOURNAL OF PATHOLOGY (2020)
Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
Ji-Yong Sung et al.
CANCERS (2020)
Targeting telomerase for cancer therapy
Adam N. Guterres et al.
ONCOGENE (2020)
Telomeres and telomerase: three decades of progress
Jerry W. Shay et al.
NATURE REVIEWS GENETICS (2019)
Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma
Lilit Nersisyan et al.
FRONTIERS IN ONCOLOGY (2019)
TelNet - a database for human and yeast genes involved in telomere maintenance
Delia M. Braun et al.
BMC GENETICS (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
Marco De Vitis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo A. Knijnenburg et al.
CELL REPORTS (2018)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
Telomeres in cancer: tumour suppression and genome instability
John Maciejowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Genomic Instability in Cancer: Teetering on the Limit of Tolerance
Noemi Andor et al.
CANCER RESEARCH (2017)
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Noemi Andor et al.
NATURE MEDICINE (2016)
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
Weiguo Zhang et al.
NATURE COMMUNICATIONS (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Khairul Ramlee et al.
GENES (2016)
The Precision Medicine Initiative A New National Effort
Euan A. Ashley
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
A. A. Chiappori et al.
ANNALS OF ONCOLOGY (2015)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement
Laura J. Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Proliferation and tissue remodeling in cancer: the hallmarks revisited
E. K. Markert et al.
CELL DEATH & DISEASE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
A. Auperin et al.
LANCET (2010)
Telomeres: protecting chromosomes against genome instability
Roderick J. O'Sullivan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Functional FEN1 Polymorphisms Are Associated with DNA Damage Levels and Lung Cancer Risk
Ming Yang et al.
HUMAN MUTATION (2009)
Mechanisms of Disease: Telomere Diseases.
Rodrigo T. Calado et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions
C. M. Raynaud et al.
ANNALS OF ONCOLOGY (2008)
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
M. H. W. Starmans et al.
BRITISH JOURNAL OF CANCER (2008)
Telomeres and human disease: Ageing, cancer and beyond
MA Blasco
NATURE REVIEWS GENETICS (2005)
High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
E Hiyama et al.
BRITISH JOURNAL OF CANCER (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Telomerase as a prognostic marker in breast cancer:: high-throughput tissue microarray analysis of hTERT and hTR
C Poremba et al.
JOURNAL OF PATHOLOGY (2002)
Telomere maintenance mechanisms as a target for drug development
DJ Bearss et al.
ONCOGENE (2000)
Share Paper
